Issue Cover

UK News

The latest from the UK pharmacuetical industry

Articles

Measles outbreak possible, advises UKHSA
Measles outbreak possible, advises UKHSA

The UKHSA has warned that further outbreaks of measles could spread to other towns and cities unless uptake in the measles, mumps and rubella vaccination is increased in at-risk areas.

7 February 2024UK News
ViroCell and Great Ormand Street Hospital receive MHRA manufacturing approval
ViroCell and Great Ormand Street Hospital receive MHRA manufacturing approval

Virocell Biologics has announced that it can now manufacture and export viral vectors from Great Ormand Street Hospital’s (GOSH) state-of-the-art manufacturing facility, the Zayed Centre for Research, for use in clinical trials.

24 November 2023UK News
MHRA grants marketing authorisation to AbbVie’s Aquipta for migraine prevention
MHRA grants marketing authorisation to AbbVie’s Aquipta for migraine prevention

AbbVie has announced that the MHRA has granted a marketing authorisation for Aquipta (atogepant), for the prophylaxis of migraine in adult patients who have had at least four migraine days each month.

5 October 2023UK News
MHRA clears Amicus Therapeutics’ Pompe disease treatment for use in the UK
MHRA clears Amicus Therapeutics’ Pompe disease treatment for use in the UK

Amicus Therapeutics has announced that the MHRA in the UK has granted marketing authorisation to pombiliti (cipaglucosidase alfa) and opfolda (miglustat) for the treatment of adult patients with late-onset pompe disease.

5 October 2023UK News
Novo Nordisk’s Wegovy (semaglutide injection) made available in the UK
Novo Nordisk’s Wegovy (semaglutide injection) made available in the UK

Novo Nordisk has today announced that Wegovy (semaglutide injection) is now available in the UK through a controlled and limited launch. The drug is intended to provide new treatment options to patients living with obesity.

5 October 2023UK News
UKHSA opens new vaccine research centre in Wiltshire to prepare for future pandemics
UKHSA opens new vaccine research centre in Wiltshire to prepare for future pandemics

Ministers have opened a new vaccine research centre at the UKHSA Porton Down campus in Wiltshire, intended to prepare for 'disease x', the next possible pandemic pathogen.

24 August 2023UK News
Bristol Myers Squibb’s Sotyktu recommended to treat adult patients with psoriasis on the NHS
Bristol Myers Squibb’s Sotyktu recommended to treat adult patients with psoriasis on the NHS

Bristol Myers Squibb has announced that NICE has recommended Sotyktu (deucravacitinib) for use on the NHS in England as a new treatment option for adult patients with moderate-to-severe plaque psoriasis.

24 August 2023UK News
Report finds NHS may miss out on new drugs due to rising costs
Report finds NHS may miss out on new drugs due to rising costs

Figures from a team at the University of York, the London School of Economics and Political Science (LSE), and the London School of Hygiene and Tropical Medicine (LSHTM) have revealed that the total cost of prescription medicines to NHS England reached a new high of £17.2bn in 2021-22, and that since 2018, NHS spending on branded medicines have been increasing by over 5% annually.

2 July 2023UK News
Trade union Unite calls for GSK staff walkouts over pay increase disputes
Trade union Unite calls for GSK staff walkouts over pay increase disputes

UK-based trade union Unite were pushing for staff walkouts at several GSK manufacturing sites due to disputes regarding pay increases, however to date there have been no updates as to whether GSK have extended another offer.

25 May 2023UK News
Pharmacists in England given wider prescribing powers to relieve GP pressure
Pharmacists in England given wider prescribing powers to relieve GP pressure

NHS England has announced that pharmacists in England will be given wider prescribing powers to relieve pressure put on GPs.

25 May 2023UK News
NICE recommends Otsuka’s Lupkynis (voclosporin) in combination treatment for active lupus nephritis
NICE recommends Otsuka’s Lupkynis (voclosporin) in combination treatment for active lupus nephritis

Otsuka Pharmaceuticals has announced that the National Institute for Health and Care Excellence (NICE) has recommended Lupkynis (Voclosporin) in combination with Mycophenolate Mofetil (MMF) as a treatment option for adult patients with active lupus nephritis (LN).

25 May 2023UK News
NICE recommends two CAR T treatments for blood cancers to the Cancer Drugs Fund
NICE recommends two CAR T treatments for blood cancers to the Cancer Drugs Fund

The National Institute for Health and Care Excellence (NICE) has announced that it is recommending two personalised immunotherapy treatments to the Cancer Drugs Fund (CDF) for the treatment of aggressive forms of blood cancers.

25 May 2023UK News